Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders.
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
pubmed:
24
2
2018
medline:
20
6
2019
entrez:
24
2
2018
Statut:
ppublish
Résumé
Blood-based biomarker discovery for psychotic disorders has yet to impact upon routine clinical practice. In physical disorders antibodies have established roles as diagnostic, prognostic and predictive (theranostic) biomarkers, particularly in disorders thought to have a substantial autoimmune or infective aetiology. Two approaches to antibody biomarker identification are distinguished: a "top-down" approach, in which antibodies to specific antigens are sought based on the known function of the antigen and its putative role in the disorder, and emerging "bottom-up" or "omics" approaches that are agnostic as to the significance of any one antigen, using high-throughput arrays to identify distinctive components of the antibody repertoire. Here we review the evidence for antibodies (to self-antigens as well as infectious organism and dietary antigens) as biomarkers of diagnosis, prognosis, and treatment response in psychotic disorders. Neuronal autoantibodies have current, and increasing, clinical utility in the diagnosis of organic or atypical psychosis syndromes. Antibodies to selected infectious agents show some promise in predicting cognitive impairment and possibly other symptom domains (eg, suicidality) within psychotic disorders. Finally, infectious antibodies and neuronal and other autoantibodies have recently emerged as potential biomarkers of response to anti-infective therapies, immunotherapies, or other novel therapeutic strategies in psychotic disorders, and have a clear role in stratifying patients for future clinical trials. As in nonpsychiatric disorders, combining biomarkers and large-scale use of "bottom-up" approaches to biomarker identification are likely to maximize the eventual clinical utility of antibody biomarkers in psychotic disorders.
Identifiants
pubmed: 29474698
pii: 4883502
doi: 10.1093/schbul/sby021
pmc: PMC6293207
doi:
Substances chimiques
Antibodies
0
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-246Références
Schizophr Bull. 2012 May;38(3):642-7
pubmed: 22446566
Front Psychiatry. 2017 Feb 16;8:25
pubmed: 28261116
J Int Med Res. 2012;40(4):1483-91
pubmed: 22971500
Schizophr Res. 2016 Sep;176(1):23-35
pubmed: 25034760
Arch Neurol. 2003 Feb;60(2):164-71
pubmed: 12580699
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
JAMA. 2013 Jun 19;309(23):2473-9
pubmed: 23780460
Am J Psychiatry. 2015 Sep 1;172(9):901-8
pubmed: 26183699
Dis Markers. 2013;35(1):3-9
pubmed: 24167344
Schizophr Res. 2013 Oct;150(1):245-51
pubmed: 23953827
J Neuropsychiatry Clin Neurosci. 2017 Summer;29(3):267-274
pubmed: 28121258
Schizophr Bull. 2006 Apr;32(2):396-400
pubmed: 16166610
Nature. 2015 Nov 19;527(7578):S155-60
pubmed: 26580321
Immunol Today. 1993 Sep;14(9):426-30
pubmed: 8216719
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):38-47
pubmed: 25695943
Epilepsia. 2014 Mar;55(3):414-22
pubmed: 24502404
Am J Psychiatry. 2017 Nov 1;174(11):1075-1085
pubmed: 27978770
Lancet Psychiatry. 2015 Dec;2(12):1117-22
pubmed: 26521769
N Engl J Med. 2010 Jul 22;363(4):301-4
pubmed: 20551152
Aliment Pharmacol Ther. 2016 Jun;43(12):1300-10
pubmed: 27117843
Diabetes. 1996 Jul;45(7):926-33
pubmed: 8666144
Schizophr Res. 2009 Feb;107(2-3):147-9
pubmed: 19008077
J Clin Oncol. 2015 Nov 20;33(33):3968-71
pubmed: 26392104
Immunol Lett. 2015 Nov;168(1):80-8
pubmed: 26386375
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):3-13
pubmed: 25325534
BMJ. 2006 Apr 15;332(7546):890-4
pubmed: 16613963
Schizophr Res. 2015 Oct;168(1-2):84-91
pubmed: 26265299
J Neuroinflammation. 2013 Jan 15;10:8
pubmed: 23320783
Clin Microbiol Rev. 2006 Jan;19(1):80-94
pubmed: 16418524
Int J Neuropsychopharmacol. 2015 Apr 21;18(10):pyv042
pubmed: 25899066
J Clin Pathol. 2000 Jun;53(6):424-32
pubmed: 10911799
JAMA Neurol. 2013 Sep 1;70(9):1133-9
pubmed: 23877059
Schizophr Res. 2014 Dec;160(1-3):193-5
pubmed: 25468187
Biol Psychiatry. 2011 Oct 1;70(7):663-71
pubmed: 21641581
Schizophr Bull. 2015 Mar;41(2):419-28
pubmed: 25103207
Asian Pac J Allergy Immunol. 2013 Dec;31(4):292-8
pubmed: 24383972
Schizophr Res. 2010 Sep;122(1-3):38-42
pubmed: 20659789
Neurol Neuroimmunol Neuroinflamm. 2016 Dec 19;4(1):e311
pubmed: 28018943
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:142-8
pubmed: 24083998
Front Psychiatry. 2017 Feb 06;8:13
pubmed: 28220082
Nat Genet. 2011 Sep 18;43(10):969-76
pubmed: 21926974
Clin Cancer Res. 2017 Jun 1;23(11):2723-2729
pubmed: 27872102
Clin Cancer Res. 2004 Feb 1;10(3):803-21
pubmed: 14871955
World Psychiatry. 2017 Jun;16(2):209-210
pubmed: 28498587
JAMA Neurol. 2017 Dec 1;74(12):1481-1491
pubmed: 29049480
Schizophr Bull. 2013 Jul;39(4):857-66
pubmed: 22446565
Psychol Med. 2018 Jan;48(2):229-244
pubmed: 28689498
PLoS One. 2013 Apr 02;8(4):e60726
pubmed: 23589757
Biol Psychiatry. 2014 Feb 15;75(4):258-9
pubmed: 24439553
BMJ. 1994 Nov 19;309(6965):1325-9
pubmed: 7866079
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):195-8
pubmed: 21933952
Seizure. 2016 Oct;41:26-41
pubmed: 27450643
Int Rev Neurobiol. 2015;122:1-51
pubmed: 26358889
Schizophr Bull. 2014 Jul;40(4):796-803
pubmed: 23943410
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):288-97
pubmed: 22100760
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Autoimmun Rev. 2016 Feb;15(2):124-38
pubmed: 26497108
J Psychiatr Res. 2014 Jun;53:119-24
pubmed: 24656425
World Psychiatry. 2013 Feb;12(1):4-15
pubmed: 23471787
Lancet Psychiatry. 2015 Mar;2(3):258-270
pubmed: 26359903
Eur Neuropsychopharmacol. 2005 Aug;15(4):399-409
pubmed: 15925493
Biol Psychiatry. 2015 Mar 15;77(6):537-47
pubmed: 25168608
Curr Psychiatry Rep. 2015 May;17(5):27
pubmed: 25773227
Parasit Vectors. 2016 Mar 10;9:137
pubmed: 26965989
Lancet. 1966 Sep 3;2(7462):512-4
pubmed: 4161638
J Neuroimmunol. 2017 Aug 15;309:51-57
pubmed: 28601288
JAMA Psychiatry. 2013 Oct;70(10):1107-12
pubmed: 23925787
J Neuroimmunol. 2017 Nov 15;312:8-14
pubmed: 28889962
Ann N Y Acad Sci. 2012 Jul;1262:56-66
pubmed: 22823436
Compr Psychiatry. 2000 Mar-Apr;41(2 Suppl 1):8-13
pubmed: 10746898
Schizophr Res. 2016 Oct;176(2-3):566-571
pubmed: 27262384
Lancet. 2007 Feb 17;369(9561):587-96
pubmed: 17307106
Transl Psychiatry. 2017 Jul 25;7(7):e1177
pubmed: 28742074
Lancet. 2004 Dec 11-17;364(9451):2106-12
pubmed: 15589308
Open Access Rheumatol. 2016 Sep 19;8:81-91
pubmed: 27843374
Psychiatry Res. 2015 Dec 15;230(2):704-8
pubmed: 26548982
Schizophr Bull. 2017 Mar 1;43(2):247-252
pubmed: 27507268
JAMA Psychiatry. 2016 Jul 1;73(7):665-74
pubmed: 27304221
Biol Psychiatry. 2014 Feb 15;75(4):284-91
pubmed: 23988024
J Psychiatr Res. 2016 Jan;72:74-81
pubmed: 26594873
Eur Neuropsychopharmacol. 2015 May;25(5):725-32
pubmed: 25092428
Biol Psychiatry. 2014 Feb 15;75(4):300-6
pubmed: 24199668
J Clin Immunol. 2010 Jan;30(1):17-23
pubmed: 19802690
Acta Psychiatr Scand. 2006 Feb;113(2):82-90
pubmed: 16423158
Am J Psychiatry. 2003 Dec;160(12):2234-6
pubmed: 14638597
Mol Psychiatry. 2017 Dec;22(12):1776-1784
pubmed: 27502473
Immunology. 2017 Nov;152(3):388-401
pubmed: 28704576
Neuropathol Appl Neurobiol. 2015 Oct;41(6):694-720
pubmed: 25944653
Transl Psychiatry. 2017 May 9;7(5):e1121
pubmed: 28485731
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Mol Genet Metab. 2014 Dec;113(4):307-14
pubmed: 25456743
J Neuroimmunol. 2016 Sep 15;298:178-80
pubmed: 27609293
J Exp Med. 2005 Aug 15;202(4):473-7
pubmed: 16087714
J Psychopharmacol. 2015 Feb;29(2):138-43
pubmed: 25601396
BMJ. 2004 Feb 21;328(7437):438-9
pubmed: 14976100
Arch Gen Psychiatry. 2003 May;60(5):466-72
pubmed: 12742867
Psychol Med. 1987 May;17(2):371-9
pubmed: 3602229
Schizophr Bull. 2015 Sep;41(5):1162-70
pubmed: 25829375
Biol Psychiatry. 2014 Mar 1;75(5):e11-3
pubmed: 23890739
Psychopharmacology (Berl). 2016 May;233(9):1605-21
pubmed: 26667479
J Neuropsychiatry Clin Neurosci. 2017 Fall;29(4):365-374
pubmed: 28449636
Expert Opin Biol Ther. 2006 Nov;6(11):1193-205
pubmed: 17049016
Diabetologia. 2015 May;58(5):980-7
pubmed: 25660258
Schizophr Bull. 2012 Nov;38(6):1137-48
pubmed: 22490995
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Front Psychiatry. 2017 Apr 21;8:64
pubmed: 28484400
Am J Psychiatry. 2015 Mar 1;172(3):219-21
pubmed: 25727533
Schizophr Bull. 2009 May;35(3):549-62
pubmed: 19325164
J Nerv Ment Dis. 2014 Aug;202(8):589-93
pubmed: 25010110
Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e280
pubmed: 27606355
Am J Psychiatry. 2010 Mar;167(3):261-80
pubmed: 20123911
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
World J Psychiatry. 2016 Mar 22;6(1):102-17
pubmed: 27014601
Lancet Psychiatry. 2017 Jan;4(1):42-48
pubmed: 27965002
Schizophr Res. 2011 Dec;133(1-3):150-5
pubmed: 21890329
Parasitol Res. 2017 Jul;116(7):1793-1799
pubmed: 28508166
Schizophr Bull. 2015 May;41(3):559-73
pubmed: 25759473
Schizophr Res. 2012 Sep;140(1-3):262-3
pubmed: 22771303
Lancet Psychiatry. 2018 Jan;5(1):79-92
pubmed: 28781208
N Engl J Med. 1999 Dec 30;341(27):2068-74
pubmed: 10615080
NPJ Schizophr. 2015 May 06;1:15013
pubmed: 27336030
J Clin Psychiatry. 2017 Jan;78(1):e18-e27
pubmed: 27929612
Brain Behav Immun. 2015 Feb;44:148-58
pubmed: 25241021
Schizophr Bull. 2007 May;33(3):737-40
pubmed: 17314085
Alzheimers Dement (Amst). 2016 Apr 12;3:51-62
pubmed: 27239548
Schizophr Res. 2012 Aug;139(1-3):161-8
pubmed: 22704639
Schizophr Res. 2014 Feb;152(2-3):521-7
pubmed: 24368154
Biol Psychiatry. 2015 Mar 15;77(6):e27-9
pubmed: 25442007
J Psychiatr Res. 2017 Apr;87:37-43
pubmed: 27988332
EMBO J. 2015 Feb 12;34(4):466-74
pubmed: 25599993